Drugs · acquisition-cost intelligence
Leader Adult Tussin Mucus and Chest Congestion 541
Guaifenesin· ingredient guaifenesin· GUAIFENESIN 200 mg/10mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.02236
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other guaifenesin products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| Adult Tussin | $0.01815 | −$0.00420 |
| Guaifenesin 200mg | $0.03140 | +$0.00900 |
| Always Save Chest Congestion Relief GUAF | $0.06723 | +$0.04490 |
| Always Save Mucus Relief PE | $0.08718 | +$0.06480 |
| 12 Hour Mucus Relief | $0.29751 | +$0.27520 |
| equate mucus d | $0.36492 | +$0.34260 |
| EQUATE MUCUS D | $0.41980 | +$0.39740 |
| basic care mucus er max | $0.44813 | +$0.42580 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.